XML 41 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Revenue- Gilead Science Inc (Details) - USD ($)
$ in Thousands
3 Months Ended
Oct. 14, 2022
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Collaboration And Other Agreements [Line Items]        
Revenues   $ 24,496 $ 11,101  
Deferred revenue, current   9,249   $ 9,988
Deferred revenue, net of current portion   58,006   59,480
Gilead | 2022 Gilead Collaboration And License Agreement        
Collaboration And Other Agreements [Line Items]        
Non-refundable upfront payment $ 60,000      
Revenues   400    
Deferred revenue   59,500   59,800
Deferred revenue, current   $ 2,100   1,800
Deferred revenue, net of current portion     $ 57,400 $ 58,000
Potential target nomination, option fees and milestone payments $ 1,700,000